会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 38. 发明专利
    • D-CYCLOALKYLBENZYL LACTAMIMIDES
    • ZA741670B
    • 1975-02-26
    • ZA741670
    • 1974-03-13
    • RICHARDSON MERRELL INC
    • CLAXTON GGRISAR J
    • C07D207/22C07D211/72C07D223/12C07D227/10C07CC07D
    • 1413455 α-Cycloalkylbenzyl lactamimides RICHARDSON-MERRELL Inc 22 April 1974 [25 April 1973] 17546/74 Heading C2C Novel compounds of Formula I wherein n is an integer of from 3 to 9; R is hydrogen or methyl; R 1 is hydrogen or lower alkyl having from 1 to 4 carbon atoms; Y is cycloalkyl having from 3 to 5 carbon atoms; X is hydrogen, lower alkoxy having from 1 to 4 carbon atoms or lower alkyl having from 1 to 4 carbon atoms; m is an integer of from 1 to 2; and the pharmaceutically acceptable acid addition salts thereof are prepared (a) when R is H by reaction of a compound of Formula V with an amine of Formula VI or where n is H or methyl, the amine is reacted with the appropriate lactam complexed with phosphorous oxychloride, phosgene, borontrifluoride etherate, dimethyl sulphate, hydrogen halide or a combination of the same. 2,3,4,5,6,6 - Hexahydro - 8 - methoxyazocine, is prepared by reacting octahydroazocin-2-one with dimethyl sulphate. α - Cyclopropylbenzylamine is prepared by reacting cyclopropyl cyanide and phenyl magnesium bromide then lithium aluminium hydride and isolated as the hydrochloride. Pharmaceutical compositions in conventional forms for oral, sublingual, intrabuccal and parenteral administration and having hypglycemic activity comprise an above novel compound and a carrier therefor.